Global Immune Repertoire Sequencing Market Size study, by Type (Assay Kits, Software & Services), by Application (Biomarker Discovery, Infectious Diseases, Vaccine Development & Efficacy, Cancer Immunotherapy, Autoimmune Diseases, Transplant Rejection & Tolerance, Others), by End-User (Academic Institutes, Research Center Diagnostic Laboratories, Others) and Regional Forecasts 2018-2025

February 2019 | 200 pages | ID: G61E95741B1EN
Bizwit Research & Consulting LLP

Abstracts

Global Immune Repertoire Sequencing Market to reach USD XX billion by 2025.

Global Immune Repertoire Sequencing Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. Immune repertoire is sub-type of proteins on organism’s immune system creates. Immune repertoire sequencing allows scientist and researchers to inspect and recognize the adoptive immune-mediated diseases. Immune repertoire sequencing is also widely accepted in cancer immunotherapy, biomarker discovery, asthma and allergy research and infectious diseases research. Increasing research & development, increasing prevalence of cancer and new launches of novel products are the driving factors of the immune repertoire sequencing market across the globe. In addition, increasing international collaboration in immune repertoire sequencing projects is creating a numerous opportunity in the market over the upcoming years. However, lack of awareness about the about the cancer diseases treatment and high cost related with sequencing platform & data analytics services are the restraining factor of the market across the globe.

The regional analysis of Global Immune Repertoire Sequencing Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasingly focus on developing novel technologies and high presence of key players in the region. Europe is also estimated to grow in market due to rapid growth in immune repertoire sequencing in the region over the forecast period. Asia-Pacific is also anticipated to exhibit higher growth rate / CAGR over the forecast period 2018-2025 due to increasing usage of immune repertoire sequencing in oncology research in the region. High prevalence of infectious diseases is substantial driver for growth of immune repertoire sequencing market in Middle East and Africa.

The market player included in this report are:

• Illumina Inc.
• Pacific Biosciences of California Inc.
• Agilent Technologies
• Oxford Nanopore Technologies Ltd.
• QIAGEN N.V.
• Thermo Fischer Scientific
• Hoffmann-La Roche Ltd.
• BGI
• Takara Bio Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

• Assay Kits
• Software & Services

By Application:

• Biomarker Discovery
• Infectious Diseases
• Vaccine Development & Efficacy
• Cancer Immunotherapy
• Autoimmune Diseases
• Transplant Rejection & Tolerance
• Others

By End-User:

• Academic Institutes
• Research Center Diagnostic Laboratories
• Others

By Regions:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• India
• Japan
• Latin America
• Brazil
• Mexico
• Rest of the World

Furthermore, years considered for the study are as follows:

• Historical year – 2015, 2016
• Base year – 2017
• Forecast period – 2018 to 2025

Target Audience of the Global Immune Repertoire Sequencing Market in Market Study:

• Key Consulting Companies & Advisors
• Large, medium-sized, and small enterprises
• Venture capitalists
• Value-Added Resellers (VARs)
• Third-party knowledge providers
• Investment bankers
• Investors

Contents

CHAPTER 1. EXECUTIVE SUMMARY

1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
  1.3.1. Immune Repertoire Sequencing Market, by Type, 2015-2025 (USD Billion)
  1.3.2. Immune Repertoire Sequencing Market, by Application, 2015-2025 (USD Billion)
  1.3.3. Immune Repertoire Sequencing Market, by End-User, 2015-2025 (USD Billion)
  1.3.4. Immune Repertoire Sequencing Market, by Region, 2015-2025 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption

CHAPTER 2. IMMUNE REPERTOIRE SEQUENCING MARKET DEFINITION AND SCOPE

2.1. Objective of the Study
2.2. Market Definition & Scope
  2.2.1. Industry Evolution
  2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

CHAPTER 3. IMMUNE REPERTOIRE SEQUENCING MARKET DYNAMICS

3.1. See Saw Analysis
  3.1.1. Market Drivers
  3.1.2. Market Challenges
  3.1.3. Market Opportunities

CHAPTER 4. IMMUNE REPERTOIRE SEQUENCING MARKET INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Buyers
  4.1.2. Bargaining Power of Suppliers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
  4.2.1. Political Scenario
  4.2.2. Economic Scenario
  4.2.3. Social Scenario
  4.2.4. Technological Scenario
4.3. Value Chain Analysis
  4.3.1. Supplier
  4.3.2. Manufacturers/Service Provider
  4.3.3. Distributors
  4.3.4. End-Users
4.4. Key Buying Criteria
4.5. Regulatory Framework
4.6. Cost Structure Analysis
  4.6.1. Raw Material Cost Analysis
  4.6.2. Manufacturing Cost Analysis
  4.6.3. Labor Cost Analysis
4.7. Investment Vs Adoption Scenario
4.8. Analyst Recommendation & Conclusion

CHAPTER 5. IMMUNE REPERTOIRE SEQUENCING MARKET, BY TYPE

5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Key Market Players
5.4. Immune Repertoire Sequencing Market, Sub Segment Analysis
  5.4.1. Assay Kits
    5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.4.2. Software & Services
    5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 6. IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION

6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Key Market Players
6.4. Immune Repertoire Sequencing Market, Sub Segment Analysis
  6.4.1. Biomarker Discovery
    6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.4.2. Infectious Diseases
    6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.4.3. Vaccine Development and Efficacy
    6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.4.4. Cancer Immunotherapy
    6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.4.5. Autoimmune Diseases
    6.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.4.6. Transplant Rejection and Tolerance
    6.4.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.4.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.4.7. Others
    6.4.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.4.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 7. IMMUNE REPERTOIRE SEQUENCING MARKET, BY END-USER

7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Key Market Players
7.4. Immune Repertoire Sequencing Market, Sub Segment Analysis
  7.4.1. Academic Institutes
    7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.4.2. Research Centers Diagnostic Laboratories
    7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.4.3. Others
    7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 8. IMMUNE REPERTOIRE SEQUENCING MARKET, BY REGIONAL ANALYSIS

8.1. Immune Repertoire Sequencing Market, Regional Market Snapshot (2015-2025)
8.2. North America Immune Repertoire Sequencing Market Snapshot
  8.2.1. U.S.
    8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.2.2. Canada
    8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3. Europe Immune Repertoire Sequencing Market Snapshot
  8.3.1. U.K.
    8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.2. Germany
    8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.3. France
    8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.4. Rest of Europe
    8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4. Asia Immune Repertoire Sequencing Market Snapshot
  8.4.1. China
    8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.2. India
    8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.3. Japan
    8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.4. Rest of Asia Pacific
    8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5. Latin America Immune Repertoire Sequencing Market Snapshot
  8.5.1. Brazil
    8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.5.2. Mexico
    8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6. Rest of The World
  8.6.1. South America
    8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.6.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.6.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.6.2. Middle East and Africa
    8.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.6.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.6.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.6.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 9. COMPETITIVE INTELLIGENCE

9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
  9.3.1. Illumina Inc.
    9.3.1.1. Overview
    9.3.1.2. Financial (Subject to Data Availability)
    9.3.1.3. Product Summary
    9.3.1.4. Recent Developments
  9.3.2. Pacific Biosciences of California Inc.
  9.3.3. Agilent Technologies
  9.3.4. Oxford Nanopore Technologies Ltd.
  9.3.5. QIAGEN N.V.
  9.3.6. Thermo Fischer Scientific
  9.3.7. Hoffmann-La Roche Ltd.
  9.3.8. BGI
  9.3.9. Takara Bio Inc.

CHAPTER 10. RESEARCH PROCESS

10.1. Research Process
  10.1.1. Data Mining
  10.1.2. Analysis
  10.1.3. Market Estimation
  10.1.4. Validation
  10.1.5. Publishing
  10.1.6. Research Assumption